The complexity of sterile pharmaceutical manufacturing requires going beyond production capabilities — it takes dynamic partnerships. Some of the most valuable partnerships for biotechnology and pharmaceutical companies are with their Contract Development and Manufacturing Organizations (CDMOs), which often involve optimizing processes from early-stage development and through continuous improvement to commercial production.